0001193125-20-189629.txt : 20200807 0001193125-20-189629.hdr.sgml : 20200807 20200708160558 ACCESSION NUMBER: 0001193125-20-189629 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stealth BioTherapeutics Corp CENTRAL INDEX KEY: 0001696396 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 190 ELGIN AVENUE STREET 2: GEORGE TOWN CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9005 BUSINESS PHONE: 617-600-6888 MAIL ADDRESS: STREET 1: 190 ELGIN AVENUE STREET 2: GEORGE TOWN CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-9005 CORRESP 1 filename1.htm CORRESP

STEALTH BIOTHERAPEUTICS CORP

c/o Intertrust Corporate Services (Cayman) Limited

190 Elgin Avenue

George Town, Grand Cayman

KY1-9005 Cayman Islands

July 8, 2020

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Stealth BioTherapeutics Corp

    

Registration Statement on Form F-1

    

File No. 333-239356

    

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-1 (File No. 333-239356), so that it may become effective at 4:00 p.m., Eastern time, on July 10, 2020, or as soon as practicable thereafter.

 

Very truly yours,

 

STEALTH BIOTHERAPEUTICS CORP

By:   /s/ Irene P. McCarthy

Name:

Title:

  

Irene P. McCarthy

Chief Executive Officer